The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wise John Drayton since 2022.
This trader's CIK number is 1930805.
At the time of last reporting, Wise John Drayton was the Chief Commercial Officer of Insmed Inc. (stock ticker symbol INSM).
Also see all insider trading activities at Insmed Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | INSM | 0 | $0 | 21,507 | $1,536,390 | 10,000 | $160,700 |
| 2024 | INSM | 0 | $0 | 36,039 | $1,191,715 | 26,321 | $462,181 |
| 2023 | INSM | 0 | $0 | 6,253 | $117,007 | 0 | $0 |
| 2022 | INSM | 0 | $0 | 258 | $7,169 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-06 | INSM | Sale | 7,910 | 80.90 | 639,919 |
| 2025-02-07 | INSM | Sale | 10 | 78.91 | 789 |
| 2025-01-07 | INSM | Option Ex | 10,000 | 16.07 | 160,700 |
| 2025-01-07 | INSM | Sale | 12,908 | 65.92 | 850,959 |
| 2025-01-08 | INSM | Sale | 392 | 66.21 | 25,954 |
| 2025-01-10 | INSM | Sale | 287 | 65.40 | 18,769 |
| 2024-05-28 | INSM | Option Ex | 6,250 | 12.58 | 78,625 |
| 2024-05-28 | INSM | Sale | 7,852 | 49.48 | 388,477 |
| 2024-05-14 | INSM | Sale | 5,088 | 25.47 | 129,591 |
| 2024-01-09 | INSM | Sale | 1,861 | 28.78 | 53,559 |
| 2024-01-03 | INSM | Sale | 20,071 | 29.19 | 585,872 |
| 2024-01-05 | INSM | Sale | 1,167 | 29.32 | 34,216 |
| 2024-01-03 | INSM | Option Ex | 20,071 | 19.11 | 383,556 |
| 2023-05-25 | INSM | Sale | 3,366 | 18.95 | 63,785 |
| 2023-05-15 | INSM | Sale | 593 | 19.29 | 11,438 |
| 2023-05-16 | INSM | Sale | 381 | 18.44 | 7,025 |
| 2023-05-17 | INSM | Sale | 1,913 | 18.17 | 34,759 |
| 2022-08-10 | INSM | Sale | 258 | 27.79 | 7,169 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wise John Drayton (Chief Commercial Officer of Insmed Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.